{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:40:51Z","timestamp":1790764851593,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00467-020-04799-7","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T22:02:16Z","timestamp":1604181736000},"page":"1195-1205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Predictors of poor kidney outcome in children with C3 glomerulopathy"],"prefix":"10.1007","volume":"36","author":[{"given":"Ay\u015fe Seda","family":"P\u0131narba\u015f\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-4344","authenticated-orcid":false,"given":"Ismail","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Gokce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"\u00c7omak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seha","family":"Sayg\u0131l\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral Torun","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Donmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Melek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demet","family":"Tekcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"\u00c7i\u00e7ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y\u0131lmaz","family":"Tabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Y.","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Bahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Koyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Soylu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur","family":"Canpolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ba\u011fdag\u00fcl","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehtap Ezel","family":"\u00c7elak\u0131l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ta\u015fdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Benzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl","family":"\u00d6z\u00e7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevcan A.","family":"Bakkalo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhan","family":"D\u00fc\u015f\u00fcnsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,31]]},"reference":[{"key":"4799_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","volume":"84","author":"MC Pickering","year":"2013","unstructured":"Pickering MC, D\u2019agati VD, Nester CM, Smith RJ, Haas M, Appel GB, Alpers CE, Bajema IM, Bedrosian C, Braun M, Doyle M, Fakhouri F, Fervenza FC, Fogo AB, Fremeaux-Bacchi V, Gale DP, Jorge EG, Harris CL, Holers VM, Johnson S, Lavin PJ, Medjeral-Thomas N, Morgan BP, Nast CC, Noel L, Peters DK, Cordoba SR, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT (2013) C3 glomerulopathy: consensus report. Kidney Int 84:1079\u20131089","journal-title":"Kidney Int"},{"key":"4799_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/MNH.0b013e32835da24c","volume":"22","author":"CM Nester","year":"2013","unstructured":"Nester CM, Smith RJ (2013) Treatment options for C3 glomerulopathy. Curr Opin Nephrol Hypertens 22:231\u2013237","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"4799_CR3","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrneph.2010.85","volume":"6","author":"F Fakhouri","year":"2010","unstructured":"Fakhouri F, Fr\u00e9meaux-Bacchi V, No\u00ebl LH, Cook HT, Pickering MC (2010) C3 glomerulopathy: a new classification. Nat Rev Nephrol 6:494\u2013499","journal-title":"Nat Rev Nephrol"},{"key":"4799_CR4","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/ki.2015.227","volume":"88","author":"C Rabasco","year":"2015","unstructured":"Rabasco C, Cavero T, Rom\u00e1n E, Rojas-Rivera J, Olea T, Espinosa M, Cabello V, Fernandez-Juarez G, Gonzales F, Avila A, Baltar MA, Diza M, Alegre R, Elias S, Anton M, Frutos MA, Pobes A, Blasco M, Martin F, Bernis C, Macias M, Barroso S, Lorenza A, Ariceta G, Lopez-Medoza M, Rivas B, Lopez-Revuelta K, Campistol JM, Mendizabal S, Cordoba SR, Praga M (2015) Effectiveness of mycophenolate mofetil in C3 glomerulonephritis. Kidney Int 88:1153\u20131160","journal-title":"Kidney Int"},{"key":"4799_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2215\/CJN.04700513","volume":"9","author":"NR Medjeral-Thomas","year":"2014","unstructured":"Medjeral-Thomas NR, O\u2019Shaughnessy MM, O\u2019Regan JA, Traynor C, Flanagan M, Wong L, Teoh CW, Awan A, Waldron M, Cairns T, O'Kelly P, Dorman AM, Pickering MC, Conlon PJ, Cook HT (2014) C3 glomerulopathy: clinicopathologic features and predictors of outcome. Clin J Am Soc Nephrol 9:46\u201353","journal-title":"Clin J Am Soc Nephrol"},{"key":"4799_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.mayocp.2018.05.019","volume":"93","author":"A Ravindran","year":"2018","unstructured":"Ravindran A, Fervenza FC, Smith RJH, De Vriese AS, Sethi S (2018) C3 glomerulopathy: ten years\u2019 experience at Mayo Clinic. Mayo Clin Proc 93:991\u20131008","journal-title":"Mayo Clin Proc"},{"key":"4799_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.smim.2016.06.001","volume":"28","author":"D Ricklin","year":"2016","unstructured":"Ricklin D, Lambris JD (2016) New milestones ahead in complement-targeted therapy. Semin Immunol 28:208\u2013222","journal-title":"Semin Immunol"},{"key":"4799_CR8","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00467-015-3311-3","volume":"31","author":"B Al-Ghaithi","year":"2016","unstructured":"Al-Ghaithi B, Chanchlani R, Riedl M, Thorner P, Licht C (2016) C3 Glomerulopathy and post-infectious glomerulonephritis define a disease spectrum. Pediatr Nephrol 31:2079\u20132086","journal-title":"Pediatr Nephrol"},{"key":"4799_CR9","doi-asserted-by":"publisher","unstructured":"Yaz\u0131l\u0131ta\u015f F, Karg\u0131n \u00c7ak\u0131c\u0131 E, Kurt \u015e\u00fck\u00fcr ED, Can G, G\u00fcng\u00f6r T, Orhan D, B\u00fclb\u00fcl M (2020) C3 glomerulopathy: experience of a pediatric nephrology center. Acta Clin Belg. https:\/\/doi.org\/10.1080\/17843286.2020.1713450","DOI":"10.1080\/17843286.2020.1713450"},{"key":"4799_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s40620-019-00672-5","volume":"33","author":"A Kumar","year":"2020","unstructured":"Kumar A, Nada R, Ramachandran R, Rawat A, Tiewsoh K, Das R, Rayat CS, Gupta KL, Vasishta RK (2020) Outcome of C3 glomerulopathy patients: largest single-centre experience from South Asia. J Nephrol 33:539\u2013550","journal-title":"J Nephrol"},{"key":"4799_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/1319-2442.279964","volume":"31","author":"AS Pinarbasi","year":"2020","unstructured":"Pinarbasi AS, Dursun I, Poyrazoglu M, Akgun H, Bozpolat A, Dusunsel R (2020) Evaluation of the children with C3 glomerulopathy. Saudi J Kidney Dis Transpl 31:79\u201389","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"4799_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","volume":"15","author":"M Dragon-Durey","year":"2004","unstructured":"Dragon-Durey M, Frmeaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschenes G, Coppo P, Fridman WH, Weiss L (2004) Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis : report and genetic analysis of 16 cases. J Am Soc Nephrol 15:787\u2013795","journal-title":"J Am Soc Nephrol"},{"key":"4799_CR13","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.kint.2017.10.022","volume":"93","author":"AS Bomback","year":"2018","unstructured":"Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, Radhakrisnan J, Marasa M, Rosenstiel PE, Herlitz LC, Markowitz GS, D'Agati VD, Appel GB (2018) C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy. Kidney Int 93:977\u2013985","journal-title":"Kidney Int"},{"key":"4799_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000479012","volume":"46","author":"Y Caliskan","year":"2017","unstructured":"Caliskan Y, Torun ES, Tiryaki TO, Oruc A, Ozluk Y, Akgul SU, Temurhan S, Oztop N, Kilicaslan I, Sever MS (2017) Immunosuppressive treatment in C3 glomerulopathy: is it really effective? Am J Nephrol 46:96\u2013107","journal-title":"Am J Nephrol"},{"key":"4799_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2215\/CJN.09080817","volume":"213","author":"RS Avasare","year":"2018","unstructured":"Avasare RS, Canetta PA, Bomback AS, Marasa M, Caliskan Y, Ozluk Y, Li Y, Gharavi AG, Appel GB (2018) Mycophenolate mofetil in combination with steroids for treatment of C3 glomerulopathy: a case series. Clin J Am Soc Nephrol 213:406\u2013413","journal-title":"Clin J Am Soc Nephrol"},{"key":"4799_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/nep.13522","volume":"24","author":"N Kojc","year":"2019","unstructured":"Kojc N, Bahovec A, Levart TK (2019) C3 glomerulopathy in children: is there still a place for anti-cellular immunosuppression? Nephrology 24:188\u2013194","journal-title":"Nephrology"},{"key":"4799_CR17","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00467-017-3702-8","volume":"32","author":"A Ravindran","year":"2017","unstructured":"Ravindran A, Fervenza FC, Smith RJH, Sethi S (2017) C3 glomerulonephritis with a severe crescentic phenotype. Pediatr Nephrol 32:1625\u20131633","journal-title":"Pediatr Nephrol"},{"key":"4799_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3109\/01913123.2015.1120837","volume":"40","author":"AA Kurien","year":"2016","unstructured":"Kurien AA, Larsen C, Rajapurkar M, Bonsib SM, Walker P (2016) Lack of electron microscopy hinders correct renal biopsy diagnosis: a study from India. Ultrastruct Pathol 40:14\u201317","journal-title":"Ultrastruct Pathol"},{"key":"4799_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ki.2012.384","volume":"83","author":"S Sethi","year":"2013","unstructured":"Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, Nasr SH, Smith RJ (2013) Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83:293\u2013299","journal-title":"Kidney Int"},{"key":"4799_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/ki.2011.399","volume":"81","author":"S Sethi","year":"2012","unstructured":"Sethi S, Nester CM, Smith RJH (2012) Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. Kidney Int 81:434\u2013441","journal-title":"Kidney Int"},{"key":"4799_CR21","doi-asserted-by":"publisher","unstructured":"Koopman JJE, Vries APJ, De Bajema IM (2019) C3 glomerulopathy. Nephrol Dial Transplant:gfz201. https:\/\/doi.org\/10.1093\/ndt\/gfz201","DOI":"10.1093\/ndt\/gfz201"},{"key":"4799_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000199459","volume":"111","author":"N Dimkovic","year":"2009","unstructured":"Dimkovic N, Jovanovic D, Kovacevic Z, Rabrenovic V, Nesic V, Savin M, Mitic B, Ratkovic M, Curis S, Mitic I, Pljesa S, Perunici-pekovic G, Marinkovic J, Popovic J, Vujic D (2009) Mycophenolate mofetil in high-risk patients with primary glomerulonephritis: results of a 1-year prospective study. Nephron Clin Pract 111:189\u2013196","journal-title":"Nephron Clin Pract"},{"key":"4799_CR23","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00467-018-4034-z","volume":"33","author":"J Holle","year":"2018","unstructured":"Holle J, Berenberg-Go\u00dfler L, Wu K, Beringer O, Kropp F, M\u00fcller D, Thumfart J (2018) Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents. Pediatr Nephrol 33:2289\u20132298","journal-title":"Pediatr Nephrol"},{"key":"4799_CR24","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1681\/ASN.2012121200","volume":"24","author":"J Gellermann","year":"2013","unstructured":"Gellermann J, Weber L, Pape L, T\u00f6nshoff B, Hoyer P, Querfeld U (2013) Mycophenolate mofetil versus cyclosporin a in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol 24:1689\u20131697","journal-title":"J Am Soc Nephrol"},{"key":"4799_CR25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1055\/s-0034-1375299","volume":"40","author":"M Vivarelli","year":"2014","unstructured":"Vivarelli M, Emma F (2014) Treatment of C3 glomerulopathy with complement blockers. Semin Thromb Hemost 40:472\u2013477","journal-title":"Semin Thromb Hemost"},{"key":"4799_CR26","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMc1111953","volume":"366","author":"M Vivarelli","year":"2012","unstructured":"Vivarelli M, Pasini A, Emma F (2012) Eculizumab for the treatment of dense-deposit disease. N Engl J Med 366:1163\u20131165","journal-title":"N Engl J Med"},{"key":"4799_CR27","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMc1112273","volume":"366","author":"E Daina","year":"2012","unstructured":"Daina E, Noris M, Remuzzi G (2012) Eculizumab in a patient with dense-deposit disease. N Engl J Med 366:1161\u20131163","journal-title":"N Engl J Med"},{"key":"4799_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2017.11.019","volume":"72","author":"M Le Quintrec","year":"2018","unstructured":"Le Quintrec M, Lapeyraque A, Lionet A, Sellier-leclerc A, Delmas Y, Baudouin V, Daugas E, Decramer S, Tricot L, Cailliez M, Dubot P, Servais A, Mourey-Epron C, Pourcine F, Loirat C, Fr\u00e9meaux-Bacchi V, Fakhouri F (2018) Patterns of clinical response to eculizumab in patients with C3 glomerulopathy. Am J Kidney Dis 72:84\u201392","journal-title":"Am J Kidney Dis"},{"key":"4799_CR29","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2215\/CJN.12901211","volume":"7","author":"AS Bomback","year":"2012","unstructured":"Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D'Agati VD, Canetta PA, Radhakrishnan J, Appel GB (2012) Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol 7:748\u2013756","journal-title":"Clin J Am Soc Nephrol"},{"key":"4799_CR30","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00467-017-3619-2","volume":"32","author":"C Lebreton","year":"2017","unstructured":"Lebreton C, Bacchetta J, Dijoud F, Bessenay L, Fremeaux-Bacchi V, Sellier-Leclerc AL (2017) C3 glomerulopathy and eculizumab: a report on four paediatric cases. Pediatr Nephrol 32:1023\u20131028","journal-title":"Pediatr Nephrol"},{"key":"4799_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/ajt.13042","volume":"15","author":"S Barbour","year":"2015","unstructured":"Barbour S, Gill JS (2015) Advances in the understanding of complement mediated glomerular disease: implications for recurrence in the transplant setting. Am J Transplant 15:312\u2013319","journal-title":"Am J Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04799-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-020-04799-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04799-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T10:12:07Z","timestamp":1617099127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-020-04799-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,31]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4799"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04799-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,31]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the local institutional Ethics Committee (2017\/209).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests and they have not received any funds or grants for this manuscript. The results presented in this paper have not been published previously in whole or part, except in abstract format.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}